SEC Filing Summary: IRSA Investments & Representations Inc.
Business Context and Reporting Period
This Form 6-K filing by IRSA Inversiones y Representaciones Sociedad Anonima (NYSE: IRS; BYMA: IRSA) covers the month of April 2026, with a specific report date of April 28, 2026. The filing serves as a notification to holders of warrants regarding the final exercise period and expiration of these instruments.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document is strictly a corporate action notice regarding warrant terms.
Material Changes and Warrant Terms
- Expiration and Exercise Dates: The final opportunity to exercise warrants is May 11 and 12, 2026, which coincides with the expiration date.
- Exercise Ratio: Each warrant entitles the holder to receive 1.6367 common shares.
- Share Par Value: Common shares have a par value of ARS 10.
- Exercise Price: The cash exercise price is USD 0.2641 per share.
- Cashless Exercise Option: Holders may elect the "Net Exercise with Par Value Contribution" modality. Under this method, holders receive shares equivalent to the difference between the cash exercise price and the market value of the business day prior to the exercise period. Holders must pay the par value of issued shares (ARS 1 per share) plus the BNY ADS issuance fee (USD 0.05 per ADS) if converting to ADS.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. A specific operational risk noted is that Caja de Valores and/or respective intermediaries may establish earlier internal cut-off dates for the receipt of exercise instructions than the official expiration dates.
Investor Verification Checklist
- Verify the current market price of IRSA common shares to determine the intrinsic value of the cashless exercise option.
- Confirm with the specific broker or intermediary regarding any internal cut-off dates that may precede May 11, 2026.
- Review the terms of the Shareholders' Meeting held on October 30, 2025, regarding the approval of the cashless exercise modality.
- Calculate the total cost basis for cashless exercise, including the ARS 1 par value and USD 0.05 ADS fee if applicable.